Evidence map›Paper›PMID 25648831›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2015

Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles.

Nora S Kayton, Gregory Poffenberger, Joseph Henske, Chunhua Dai, Courtney Thompson, Radhika Aramandla, Alena Shostak, Wendell Nicholson, Marcela Brissova, William S Bush and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Donor- and isolation-related predictive factors ofFrontiers in endocrinology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Nora S KaytonDepartment of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee;
Gregory PoffenbergerDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Joseph HenskeDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Chunhua DaiDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Courtney ThompsonDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Radhika AramandlaDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Alena ShostakDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Wendell NicholsonDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Marcela BrissovaDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
William S BushCenter for Human Genetics Research, Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Alvin C PowersDepartment of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee al.powers@vanderbilt.edu.
Vanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and RegenerationU01DK089572 · NIDDK · VANDERBILT UNIVERSITY · PI GREINER, DALE LESLIE, HARLAN, DAVID MARSHALL · 2010 to 2014
$8.4M
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human PancreasUC4DK104211 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIM, SEUNG K, POWERS, ALVIN C · 2014 to 2015
$4.0M
Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell ReplicationU01DK089538 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 2010 to 2014
$3.6M
Islet Biology in Cystic Fibrosis Related DiabetesR01DK097829 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI AGUILAR-BRYAN, LYDIA, POWERS, ALVIN C · 2012 to 2016
$2.9M
Reconstruction of Human Type 1 Diabetes in MiceR24DK092758 · NIDDK · HARVARD UNIVERSITY · PI MELTON, DOUGLAS A · 2011 to 2011
$2.3M
Islet Imaging with Monoclonal AntibodiesR01DK094199 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LIU, GUOZHENG, POWERS, ALVIN C · 2011 to 2015
$2.1M
GLP-1 to Enhance Islet TransplantationR33DK066636 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 2005 to 2007
$1.5M
VEGF and Islet VascularizationR01DK069603 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 2005 to 2010
$1.3M
Molecular Determinants of Vascularization in IsletsR21DK063439 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN CARTER · 2002 to 2003
$755k
GLP-1 to Enhance Islet TransplantationR21DK066636 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN CARTER · 2003 to 2004
$722k
NIDDK NIH HHS DK-104211NIDDK NIH HHS DK-20593NIDDK NIH HHS DK-62641NIDDK NIH HHS DK-63439NIDDK NIH HHS DK-66636NIDDK NIH HHS DK-68764NIDDK NIH HHS DK-68854NIDDK NIH HHS DK-69603NIDDK NIH HHS DK-72473NIDDK NIH HHS DK-89538NIDDK NIH HHS DK-89572NIDDK NIH HHS DK-92758NIDDK NIH HHS DK-94199NIDDK NIH HHS DK-97829NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK094199NIDDK NIH HHS UC4 DK104211
6 · The paper itself

Abstract

Human islet research is providing new insights into human islet biology and diabetes, using islets isolated at multiple US centers from donors with varying characteristics. This creates challenges for understanding, interpreting, and integrating research findings from the many laboratories that use these islets. In what is, to our knowledge, the first standardized assessment of human islet preparations from multiple isolation centers, we measured insulin secretion from 202 preparations isolated at 15 centers over 11 years and noted five distinct patterns of insulin secretion. Approximately three quarters were appropriately responsive to stimuli, but one quarter were dysfunctional, with unstable basal insulin secretion and/or an impairment in stimulated insulin secretion. Importantly, the patterns of insulin secretion by responsive human islet preparations (stable Baseline and Fold stimulation of insulin secretion) isolated at different centers were similar and improved slightly over the years studied. When all preparations studied were considered, basal and stimulated insulin secretion did not correlate with isolation center, biological differences of the islet donor, or differences in isolation, such as Cold Ischemia Time. Dysfunctional islet preparations could not be predicted from the information provided by the isolation center and had altered expression of genes encoding components of the glucose-sensing pathway, but not of insulin production or cell death. These results indicate that insulin secretion by most preparations from multiple centers is similar but that in vitro responsiveness of human islets cannot be predicted, necessitating preexperimental human islet assessment. These results should be considered when one is designing, interpreting, and integrating experiments using human islets.

Indexed as

ResearchTissue and Organ ProcurementTissue DonorsAdolescentAdultAgedChildFemaleHumansInsulinInsulin SecretionIslets of LangerhansMaleMiddle AgedSpecimen HandlingYoung AdultInsulinfunctionhumanislet

Identifiers

PMID25648831
PMCPMC4385877
OpenAlexW2015528355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.